RBC Capital: 'On balance we think readthroughs from the GSK acquisition of NUVB's key competitor are positive' Jun 9, 2026 11:32AM
Nuvation Bio to Participate in Upcoming Investor Conferences May 5, 2026 04:05PM
Nuvation Bio Inc (NUVB) PT Raised at RBC Capital; ' High-reward opportunity looks compelling' Apr 6, 2026 07:04AM
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone' Sep 11, 2025 08:18AM
Nuvation Bio Inc (NUVB) PT Lowered to $6 at RBC Capital Jun 17, 2025 10:13AM


May 12, 2025 04:05PM Nuvation Bio to Participate in Upcoming Investor Conferences
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Apr 17, 2024 07:06AM Nuvation Bio Inc (NUVB) PT Raised to $5 at RBC Capital
Apr 6, 2021 08:26AM RBC Capital Starts Nuvation Bio Inc (NUVB) at Outperform